Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Bristol Myers Squibb adopts positive CHMP opinion for Opdivo plus Yervoy for patients with Microsatellite instability high or mismatch repair deficient metastatic colorectal cancer
Bristol Myers Squibb
Productivity and Economic Advantages of Coupling Single-Pass Tangential Flow Filtration to Multi-Column Chromatography for Continuous Processing
Mark Schofield, Ph.D., Karl Rogler, Xhorxhi Gjoka, Engin Ayturk, Ph.D., and René Gantier, Ph.D.
Single-Use-Systems: Leachable Study Design for Single-Use Components
Kathryn McGohan,Scientist, Global Manufacturing Sciences & Technology organization at Bristol-Myers Squibb
Current Status of Analytical Techniques for Characterization of Protein Stability
Dr. Sanket Patke, Research Investigator at Bristol-Myers Squibb with Dr. Joshua Stillahn and Dr Manning
View All Featured ArticlesHeadline News
Livdelzi improves ALP normalisation rates in Phase III PBC study
Zura Bio discontinues tibulizumab development in hidradenitis suppurativa after Phase II miss
Onchilles reports early systemic activity with intratumoral N17350 in Phase I/II trial
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Efficient execution of biologics manufacturing – The role of Finite Scheduling systems as part of sound business process from planning to floor operations.
Presented by Gloria Gadea-Lopez, Ph.D., John Maguire and Megan Rabideau
14th February 2018
Exosome Manufacture Based on the iCELLis® Bioreactor Platform
Presented by David Haylock, CEO VivaZome Therapuetics and Roberto Ciboldi, Senior Scientist, Purification Team, Scientific & Laboratories Services Pall Corporation
11th May 2021
Successful Scale Up of a High Yielding Viral Vector Suspension Platform to 500 L
Presented by John Ketz, Process Development Senior Scientist, Andelyn Biosciences, Denis Kole, Director - AcceleratorSM Processes Development Services, Pall Corporation and Benben Song, Product Manager Services, Pall Corporation
12th July 2022
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
From Compliance to Circularity: Three Ways Pharma Manufacturers Can Rethink Resource Management
Rationale Design of Valves for Flexible Processing
Strategy Emerging Markets for Risk Mitigation
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
